Sumatriptan 100 mg Oral Tablet Dosing
For acute migraine treatment in adults, sumatriptan 100 mg orally should be taken at the onset of migraine symptoms, with a second 100 mg dose permitted after 2 hours if needed, not to exceed 200 mg in 24 hours. 1
Standard Dosing Protocol
- Initial dose: 100 mg orally at the first sign of migraine headache 1
- Repeat dosing: A second 100 mg dose may be taken after 2 hours if the headache persists or returns 1
- Maximum daily dose: 200 mg in any 24-hour period 1
Optimal Timing for Administration
- Take medication early when pain is still mild rather than waiting until pain becomes moderate or severe; early treatment results in approximately 50% of patients achieving pain freedom at 2 hours versus only 28% when treatment is delayed 2
- Sumatriptan should be administered at migraine onset, not during the aura phase 3
Efficacy Expectations
- Oral sumatriptan 100 mg reduces headache from moderate or severe to mild or none within 2 hours in 50–73% of patients 4
- Complete pain freedom at 2 hours occurs in approximately 28% of patients taking 100 mg versus 11% with placebo (NNT 6.1) 2
- For headache relief (pain reduced to mild or none) at 2 hours, the NNT is 3.5 5
Combination Therapy for Enhanced Efficacy
- Adding an NSAID (naproxen 500 mg) to sumatriptan 100 mg is superior to either agent alone, providing 130 additional patients per 1,000 with sustained pain relief at 48 hours and 90 more patients per 1,000 with pain relief at 2 hours (NNT 3.5) 2
- If sumatriptan 100 mg alone provides insufficient relief after 2–3 separate migraine attacks, add an NSAID rather than increasing triptan dose or frequency 1
Trial Period Before Switching
- Each dose must be evaluated over 2–3 distinct headache episodes before determining it is ineffective 1
- If inadequate response occurs after appropriate dosing for 2–3 attacks, switching to another triptan (rizatriptan, eletriptan, zolmitriptan) is recommended, as failure of one triptan does not predict failure of others 2, 1
Medication-Overuse Prevention
- Limit sumatriptan use to ≤2 days per week (≤10 days per month) to prevent medication-overuse headache, which can paradoxically increase headache frequency and lead to daily headaches 2, 1
- If acute treatment is needed more than twice weekly, preventive therapy should be initiated immediately 2
Headache Recurrence Management
- Approximately 40% of patients experience headache recurrence within 8–24 hours after initial response 4, 3
- A second 100 mg dose may be taken if headache returns, respecting the 2-hour minimum interval and 200 mg daily maximum 1
Absolute Contraindications
- Ischemic heart disease, previous myocardial infarction, or Prinzmetal (variant) angina 1, 3
- Uncontrolled hypertension 1, 3
- Hemiplegic or basilar migraine 1, 3
- Concurrent use of ergotamine, dihydroergotamine (DHE), or another triptan within 24 hours 1
- Current MAOI use 1
Common Adverse Events
- Oral sumatriptan 100 mg produces approximately 90 more mild adverse events per 1,000 treated patients compared with placebo 2
- Common side effects include nausea, vomiting, malaise, fatigue, and dizziness 3
- Chest symptoms (pressure, heaviness, warmth) occur in 3–5% of patients but have been associated with myocardial ischemia only in rare isolated cases 1, 3
- Adverse events are generally transient and mild 6, 7
Alternative Routes When Oral Route Fails
- If oral sumatriptan 100 mg plus NSAID combination fails after adequate trial, consider subcutaneous sumatriptan 6 mg, which provides the highest efficacy (59% pain-free at 2 hours, NNT 2.3) with onset within 15 minutes 2, 5
- Intranasal sumatriptan 20 mg is particularly useful when significant nausea or vomiting is present 2